Literature DB >> 18803276

Pleural fluid findings as prognostic factors for malignant pleural mesothelioma.

Tanseli Efeoglu Gonlugur1, Ugur Gonlugur.   

Abstract

The aim of this study was to determine the prognostic value of pleural fluid glucose, lactate dehydrogenase (LDH), albumin, total protein, and total leukocyte levels in patients with malignant pleural mesothelioma. We retrospectively analyzed 71 consecutive patients (33 men and 38 women) who were referred to the department of chest diseases in a university hospital. Pleural fluid glucose levels, the ratio of pleural fluid to serum LDH>1.0, and total leukocyte count were significant predictors for the survival in univariate analysis. However, none of these variables emerged as statistically significant from the multivariate Cox model. In conclusion, our results showed that there is an inverse correlation between the intensity of inflammation and survival. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803276      PMCID: PMC6649248          DOI: 10.1002/jcla.20266

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.

Authors:  C M Burrows; W C Mathews; H G Colt
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

2.  Thoracoscopic talc poudrage in malignant pleural effusions: effective pleurodesis despite low pleural pH.

Authors:  Y Aelony; R R King; C Boutin
Journal:  Chest       Date:  1998-04       Impact factor: 9.410

3.  Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies.

Authors:  F Rodriguez-Panadero; J Lopez-Mejias
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

Review 4.  Pathology of malignant mesothelioma.

Authors:  R L Attanoos; A R Gibbs
Journal:  Histopathology       Date:  1997-05       Impact factor: 5.087

5.  Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications.

Authors:  S A Sahn; J T Good
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

6.  Effects of tube thoracostomy on pleural fluid characteristics in sheep.

Authors:  P Carvalho; W Kirk; J Butler; N B Charan
Journal:  J Appl Physiol (1985)       Date:  1993-06

7.  The distinction between transudates and exudates.

Authors:  Ugur Gonlugur; Tanseli Efeoglu Gonlugur
Journal:  J Biomed Sci       Date:  2005-10-14       Impact factor: 8.410

8.  Survival and talc pleurodesis in metastatic pleural carcinoma, revisited. Report of 125 cases.

Authors:  A Sanchez-Armengol; F Rodriguez-Panadero
Journal:  Chest       Date:  1993-11       Impact factor: 9.410

9.  Pleural fluid analysis in malignant mesothelioma. Prognostic implications.

Authors:  A Gottehrer; D A Taryle; C E Reed; S A Sahn
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

Review 10.  The differential diagnosis of pleural effusions.

Authors:  S A Sahn
Journal:  West J Med       Date:  1982-08
  10 in total
  2 in total

1.  Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.

Authors:  Ricardo Mingarini Terra; Leila Antonangelo; Alessandro Wasum Mariani; Ricardo Lopes Moraes de Oliveira; Lisete Ribeiro Teixeira; Paulo Manuel Pego-Fernandes
Journal:  Lung       Date:  2016-06-14       Impact factor: 2.584

2.  Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds.

Authors:  Giovanna Li Petri; Btissame El Hassouni; Rocco Sciarrillo; Niccola Funel; Giulia Mantini; Eveline A Zeeuw van der Laan; Stella Cascioferro; Amir Avan; Paolo Andrea Zucali; Nadia Zaffaroni; Tonny Lagerweij; Barbara Parrino; Kees Smid; Marcello Deraco; Carlotta Granchi; Alicja Braczko; Ryszard T Smolenski; Larry H Matherly; Gerrit Jansen; Yehuda G Assaraf; Patrizia Diana; Jacqueline Cloos; Godefridus J Peters; Filippo Minutolo; Elisa Giovannetti
Journal:  Br J Cancer       Date:  2020-06-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.